EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access · CC BY 4.0

Antiviral Treatment for Congenital Cytomegalovirus Infection in Extremely Preterm Newborn: A Case Report and Literature Review

Giovanni Boscarino iD, Giusy Davino, Silvia Pezzoni, Mara Corradi, Maria Carmela Pera iD, Susanna Esposito iD, Enzo Romanini

Viruses · 20.03.2026 · 18 (3) · 391

DOI: 10.3390/v18030391 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Viruses, online erschienen am 20.03.2026. Verfasst von Giovanni Boscarino und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Clinic, Pietro Barilla Children's Hospital, University Hospital of Parma, 43126 Parma, Italy. Hauptthemen laut MEDLINE: Antiviral Agents, Cytomegalovirus Infections, Infant, Extremely Premature. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Congenital cytomegalovirus (cCMV) infection is one of the most common congenital infections worldwide and the leading cause of non-genetic sensorineural hearing loss. Although less frequent in preterm infants, cCMV may significantly worsen outcomes in an already vulnerable population. The risks and benefits of antiviral therapy in extremely preterm neonates remain unclear, as this group is largely excluded from clinical trials. Case presentation: We report a case of symptomatic cCMV infection in an extremely preterm infant born at 26 weeks and 2 days of gestation to a mother with primary CMV infection during the second trimester. High CMV viral loads were detected in urine and plasma shortly after birth. On day of life (DOL) 3, respiratory deterioration required intubation, with radiological findings consistent with CMV pneumonia and positive bronchoaspirate samples. Intravenous ganciclovir was initiated on DOL 16 and administered for six weeks, followed by oral valganciclovir for six months. Treatment was associated with a favourable clinical and virological response and no significant hematological toxicity. Ophthalmologic and audiological evaluations were normal. Neurodevelopmental assessment with Bayley III at one year of corrected age demonstrated age-appropriate performance across all domains.

Discussion

A structured literature review identified 10 case reports, including 13 extremely preterm infants treated for cCMV infection. Antiviral dosing regimens were heterogeneous. The most frequent manifestations prompting treatment were laboratory abnormalities (92.3%), particularly thrombocytopenia and leukopenia or neutropenia. Neuroimaging abnormalities and intrauterine growth restriction or small for gestational age were each reported in 53.8% of cases. Long-term neurodevelopmental outcomes were normal in 38.5% of infants.

Conclusions

Antiviral therapy for cCMV infection with ganciclovir and valgancyclovir in premature neonates is feasible and safe with careful monitoring, and appears to provide benefits. Nevertheless, well-designed studies that include pharmacokinetics and pharmacodynamics, virologic monitoring, and long term outcomes of development, vision and hearing are urgently needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsCytomegalovirus InfectionsInfant, Extremely PrematureFemaleHumansInfant, NewbornPregnancyCytomegalovirusGanciclovirTreatment OutcomeValganciclovirViral Load

Stichwörter der Autor:innen

CMVantiviralcritical ill newbornganciclovirneutropeniaprematurityvalganciclovir

Substanzen

Antiviral AgentsGanciclovirValganciclovir

Autor:innen und Institutionen

  • Pediatric Clinic, Pietro Barilla Children's Hospital, University Hospital of Parma, 43126 Parma, Italy.
  • Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.
  • Neonatal Intensive Care Unit, Pietro Barilla Children's Hospital, University Hospital of Parma, 43126 Parma, Italy.

ORCID-Profile: Giovanni Boscarino, Maria Carmela Pera, Susanna Esposito

Zitieren

APA

Boscarino, G., Davino, G., Pezzoni, S., Corradi, M., Pera, M. C., Esposito, S., & Romanini, E. (2026). Antiviral Treatment for Congenital Cytomegalovirus Infection in Extremely Preterm Newborn: A Case Report and Literature Review. Viruses, 18(3), 391. https://doi.org/10.3390/v18030391

Vancouver

Boscarino G, Davino G, Pezzoni S, Corradi M, Pera MC, Esposito S, et al. Antiviral Treatment for Congenital Cytomegalovirus Infection in Extremely Preterm Newborn: A Case Report and Literature Review. Viruses. 2026;18(3):391. doi:10.3390/v18030391

BibTeX
@article{Boscarino2026,
  author = {Boscarino, Giovanni and Davino, Giusy and Pezzoni, Silvia and Corradi, Mara and Pera, Maria Carmela and Esposito, Susanna and Romanini, Enzo},
  title = {Antiviral Treatment for Congenital Cytomegalovirus Infection in Extremely Preterm Newborn: A Case Report and Literature Review},
  journal = {Viruses},
  year = {2026},
  volume = {18},
  number = {3},
  pages = {391},
  doi = {10.3390/v18030391}
}
Kostenlos starten →